 effect gemfibrozil treatment sulfonylurea-tr patient noninsulin-depend diabet mellitu studi assess gemfibrozil abil plasma triglycerid TG concentr patient niddm determin effect chang glycem control measur mean hourli plasma glucos insulin TG ffa concentr respons test meal hepat glucos product hgp insulin-stimul glucos uptak hyperinsulinem glucos clamp studi mcr plasma lipoprotein TG cholesterol concentr patient niddm month gemfibrozil treatment ambient plasma TG ffa concentr plasma glucos insulin hgp concentr plasma glucos insulin hgp glucos mcr chang patient group plasma glucos level mmol/l fair control level mmol/l good control differ phenomenon patient fair control signific decreas mean hourli plasma concentr glucos mmol/l insulin pmol/l ffa mumol/l hgp mumol/kg.min increas glucos mcr ml/kg.min associ fall TG mmol/l low densiti lipoprotein cholesterol mmol/l ratio total high densiti cholesterol signific fall mean hourli TG concentr mmol/l insulin ffa hgp glucos mcr patient good control mean hourli plasma glucos concentr mmol/l low densiti lipoprotein cholesterol group mmol/l ratio total high densiti cholesterol